| Financial Year |
March 31 2023 |
| Monetary Funds |
1,281,208,952.11 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
133,469,969.59 |
| Accounts Receivable |
2,859,735,628.11 |
| Advances to Suppliers |
199,753,345.24 |
| Other Receivables |
162,199,936.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,717,650,438.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,205,178.81 |
| Total Current Assets |
6,572,032,498.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
23,927,876.22 |
| Investment Properties |
17,072,410.51 |
| Fixed Assetes |
1,175,460,896.80 |
| Under-construction Projects |
69,749,554.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
344,298,677.59 |
| R&D expenses |
182,970,479.89 |
| Goodwill |
91,727,481.11 |
| Long-Term Deferred and Prepaid Expenses |
24,142,205.51 |
| Deferred Income Tax Assets |
258,552,374.82 |
| Other Non-Current Assets |
140,453,466.60 |
| Sub-Total of Non-Current Assets |
2,672,402,054.96 |
| Total Assets |
9,244,434,553.47 |
| Short-Term Loans |
636,430,752.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
355,219,507.56 |
| Accounts Payable |
708,070,652.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
128,705,801.03 |
| Taxes Payable |
184,251,100.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,285,788,994.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
119,701,269.38 |
| Other Current Liabilities |
55,797,805.71 |
| Sub-Total of Current Liabilities |
3,569,616,633.56 |
| Long-term Loans |
60,099,937.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
34,692,616.57 |
| Deferred Income Tax Liabilities |
18,951,103.29 |
| Other Non-Current Liabilities |
38,274,308.93 |
| Sub-Total of Non-Current Liabilities |
405,451,038.16 |
| Total Liabilities |
3,975,067,671.72 |
| Paid-In Capital(Or Share Stock) |
758,127,769.00 |
| Capital Surplus |
1,160,025,686.26 |
| Surplus Reserve |
355,389,859.80 |
| LESS:Treasury Stock |
11,849,488.56 |
| Undistributed Profits |
2,846,219,014.63 |
| Minority Stockholder's Interest |
155,421,127.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,113,945,754.17 |
| Owner's Equity（Stockholder's Equity） |
5,269,366,881.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,244,434,553.47 |
